FPMAJ Opposes Removing Exceptions for 80% Pricing Rule for Racemic Body-Derived Drugs

September 26, 2013
FPMAJ Chairman Haruo Naito (right) The Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ) on September 25 took issue with a proposal to eliminate two of the three exceptions currently set for an 80% pricing rule used to calculate the...read more